A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs

Abstract Introduction Rheumatoid arthritis (RA) guidelines recommend methotrexate (MTX)-anchored therapy with biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs); however, tolerability issues often lead to non-adherence. Canadian data on MTX tapering and/or withdrawal f...

Full description

Bibliographic Details
Published in:Rheumatology and Therapy
Main Authors: Louis Bessette, Brandusa Florica, Latha Naik, Dalton Sholter, Pierre-André Fournier, Tanya Girard, Dalinda Liazoghli, Philip A. Baer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-07-01
Subjects:
Rheumatoid arthritis
Methotrexate
Therapy
Antirheumatic agents
Online Access:https://doi.org/10.1007/s40744-024-00696-9

Internet

https://doi.org/10.1007/s40744-024-00696-9

Similar Items